Cargando…

What is the optimum systemic treatment for advanced/metastatic renal cell carcinoma of favourable, intermediate and poor risk, respectively? A systematic review and network meta-analysis

PURPOSE: The optimum systemic therapies for advanced/metastatic renal cell carcinoma (RCC) of favourable, intermediate and poor risk have not been established. We aimed to compare and rank the effects associated with systemic therapies in the first-line setting. METHODS: We searched PubMed, Cochrane...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Guanghui, Wu, Xiaoqiang, Wang, Zhiwei, Tian, Xiangyong, Zhang, Chan, Wu, Xuan, Zhang, Haotian, Jing, Gaopeng, Yan, Tianzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Urology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454197/ https://www.ncbi.nlm.nih.gov/pubmed/32859659 http://dx.doi.org/10.1136/bmjopen-2019-034626

Ejemplares similares

Antibiotic ampicillin induces immune tolerance in renal transplantation by regulating the proportion of intestinal flora in mice
por: Wu, Xiaoqiang, et al.
Publicado: (2022)

circCEP128 Knockdown Suppresses Bladder Cancer Progression via Regulating microRNA-515-5p/SDC1 Axis
por: Cao, Guanghui, et al.
Publicado: (2021)

Fecal Microbiota Transplantation as an Effective Treatment for Carbapenem-Resistant Klebsiella pneumoniae Infection in a Renal Transplant Patient
por: Wang, Junpeng, et al.
Publicado: (2021)

Metagenomic Next-Generation Sequencing Reveals the Profile of Viral Infections in Kidney Transplant Recipients During the COVID-19 Pandemic
por: Tian, Xiangyong, et al.
Publicado: (2022)

Adjuvant Hyperthermic Intravesical Chemotherapy in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer
por: Magalhães, Joana C, et al.
Publicado: (2023)

Adjustable Male Sling for The Treatment of Postprostatectomy Stress Urinary Incontinence: Intermediate-Term Follow-Up Results
por: Yanaral, Fatih, et al.
Publicado: (2023)

Rarest of the Rare Metastatic Tubulocystic Carcinoma of Kidney
por: Yousuf, Hira, et al.
Publicado: (2020)

Metastatic Prostate Adenocarcinoma: A Rare Presentation
por: Rodriguez, Pierre, et al.
Publicado: (2022)

Role of immune checkpoint inhibitor-based therapies for metastatic renal cell carcinoma in the first-line setting: A Bayesian network analysis
por: Wang, Junpeng, et al.
Publicado: (2019)

Metastatic Pleural Effusion: An Unusual Presentation of Urothelial Bladder Carcinoma
por: Javed, Isma N, et al.
Publicado: (2019)

What Is the Effect of Inguinal Hernia Operations on Sexual Functions?
por: Cantay, Hasan, et al.
Publicado: (2022)

Metastatic Renal Cell Cancer Instigating Paraplegia in a Male Patient
por: Al Rashed, Ahmed A, et al.
Publicado: (2022)

Management of Metastatic Renal Cell Carcinoma in a Tertiary Care Hospital
por: Kumar, Sanjeev, et al.
Publicado: (2023)

An Unusual Case of Metastatic Prostate Cancer Presenting as a Massive Urinoma
por: Dhawan, Vikas, et al.
Publicado: (2023)

Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma
por: Schlemmer, Marcus, et al.
Publicado: (2019)

Spontaneous Rupture of the Renal Pelvis Due to Extrinsic Obstruction by Metastatic Retroperitoneal Lymphadenopathy
por: Fink, Benjamin A, et al.
Publicado: (2022)

Metastatic Adenocarcinoma of the Prostate to the Brain Initially Suspected as Meningioma by Magnetic Resonance Imaging
por: Son, Young, et al.
Publicado: (2020)

Metastatic Renal Cell Carcinoma to the Scalp: A Case Report With Review of Literature
por: Meshikhes, Huda A, et al.
Publicado: (2023)

Synchronous Metastatic Clear Cell Renal Cell Carcinoma to the Gallbladder With Metachronous Contralateral Recurrence
por: Pierce, Daniel P, et al.
Publicado: (2021)

Exophytic Mass Around the Tip of the Nose: Unusual Presentation of Metastatic Renal Cell Carcinoma
por: Randhawa, GS, et al.
Publicado: (2022)

Small Bowel Intussusception Secondary to Metastatic Renal Cell Carcinoma: A Case Report
por: Barros, Pedro, et al.
Publicado: (2023)

Metastatic Prostate Adenocarcinoma Presenting as Acute Quadriplegia: A Case Report and Racial Disparity Analysis
por: Obaed, Nadia G, et al.
Publicado: (2022)

Does Diversion in Poorly Functioning Obstructed Kidneys in Adults Favors Reconstructive Surgeries Over Ablative Procedures? A Prospective Study
por: Kalra, Sidhartha, et al.
Publicado: (2020)

Pazopanib-Induced Liver Injury in Patients With Metastatic Renal Cell Carcinoma: A Report of Two Cases
por: Ouchi, Ryusuke, et al.
Publicado: (2022)

High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trial
por: Nair-Shalliker, Visalini, et al.
Publicado: (2021)

Prolonged Response to an IGF-1 Receptor Antibody in a Patient with Metastatic Castration Prostate Cancer with Neuroendocrine Differentiation
por: Graff, Julie N, et al.
Publicado: (2015)

What is the risk of prostate cancer mortality following negative systematic TRUS-guided biopsies? A systematic review
por: Kawa, Sandra Miriam, et al.
Publicado: (2020)

Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic review
por: Thurtle, David, et al.
Publicado: (2019)

TripleAiM1: a nationwide registry of de novo metastatic hormone-sensitive prostate cancer with prospective quality-of-life assessment
por: van Elst, Tessa, et al.
Publicado: (2023)

Temporary Tumor Shrinkage Following Enfortumab Vedotin Therapy for Metastatic Urothelial Carcinoma After Radical Cystectomy With Neoadjuvant Chemotherapy: A Case Report
por: Namiki, Sanae, et al.
Publicado: (2023)

‘What does that mean?’: a qualitative exploration of the primary and secondary clinical care experiences of young people with continence problems in the UK
por: Whale, Katie, et al.
Publicado: (2017)

Efficacy and safety of apalutamide in patients with metastatic castration-resistant prostate cancer (GENESIS): protocol for a multicentre, open-label, single-arm clinical trial
por: Miyake, Hideaki, et al.
Publicado: (2023)

Long-term Survival in a Patient with Metastatic Spinal Cord Compression from a Prostate Cancer with Ultra-high PSA: Case Report and Review of the Literature
por: Nguyen, Nhu Tram, et al.
Publicado: (2015)

Local and systemic morbidities of de novo metastatic prostate cancer in Singapore: insight from 685 consecutive patients from a large prospective Uro-oncology registry
por: Tan, Yu Guang, et al.
Publicado: (2020)

Comparison of photoselective green light laser vaporisation versus traditional transurethral resection for benign prostate hyperplasia: an updated systematic review and meta-analysis of randomised controlled trials and prospective studies
por: Lai, Shicong, et al.
Publicado: (2019)

Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial
por: Connor, Martin John, et al.
Publicado: (2021)

Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study
por: Ahlberg, Mats Steinholtz, et al.
Publicado: (2022)

Metastatic prostate cancer men’s attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment study
por: Connor, Martin John, et al.
Publicado: (2021)

COVID-19 in a Kidney Transplant Patient
por: Wang, Junpeng, et al.
Publicado: (2020)

Expression Profiling of Exosomal miRNAs Derived from the Peripheral Blood of Kidney Recipients with DGF Using High-Throughput Sequencing
por: Wang, Junpeng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qv97r0hotlnnhsdqbb45fng6md